BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

CanSinoBIO’s iPneucia® Vaccine Targets Deadly Pneumococcal Threat in Chinese Children with Precision and Safety

Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single ...

June 23, 2025 | News

Everest Medicines Releases First Clinical Batch of mRNA Cancer Vaccine EVM14, Advancing Trials in China and the U.S.

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeut...

June 23, 2025 | News

Immuno Cure and PharmaJet Partner on Needle-Free HIV Therapeutic Vaccine Study in Hong Kong

Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboratio...

June 20, 2025 | News

Clover Biopharma Begins Phase I Trial of Respiratory Combination Vaccines in Older Adults

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovat...

June 18, 2025 | News

MSD Launches Phase 3 MOBILIZE-1 Trial for Single-Dose Dengue Vaccine V181 in Asia-Pacific

MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program Study will evaluate a single dos...

June 16, 2025 | News

ASCO 2025 Showcases New Oncology Paradigms, From Breast Cancer Breakthroughs to AI-Led Precision Medicine

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting wasn’t just another scientific gathering and it was a seismic event that redrew ...

June 06, 2025 | Report

Vietnam, VNVC Partner with Sanofi to Launch Local Vaccine Manufacturing and Boost Public Health Preparedness

Sanofi and the Vietnam Vaccine Company (VNVC) have officially launched a strategic collaboration focused on technology transfer for vaccine manufacturing. ...

May 28, 2025 | News

SK Bioscience Wins Supreme Court Patent Battle Against Pfizer Over Pneumococcal Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that it the Supreme C...

May 22, 2025 | News

IDT Biologika Ramps Up Global CDMO Expansion Following SK Bioscience Acquisition

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that IDT Biologika, a...

May 21, 2025 | News

AIM Vaccine Secures PRC Clinical Approval for mRNA Shingles Vaccine, Strengthening Global Race in Next-Gen Immunization

While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660....

May 20, 2025 | News

SK Bioscience to Lead Korea’s Avian Influenza Vaccine Development Under KRW 5.25B Pandemic Preparedness Program

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has bee...

May 07, 2025 | News

Turn Therapeutics Achieves Breakthrough in Room-Temperature Vaccine Stability with 100% Live Virus Recovery

Turn Therapeutics, a clinical-stage pharmaceutical and medical device company, announced that it has achieved a critical milestone in its effort to r...

May 05, 2025 | News

Aptamer Group and University of Glasgow Partner to Advance Optimer-Based Vaccine Adjuvants for Swine Health

Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has ente...

May 01, 2025 | News

SK Bioscience Wins Patent Case Against Moderna Clearing Path for Global mRNA Vaccine Development

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has won...

April 24, 2025 | News

Stay Connected